Literature DB >> 15882070

Mechanism of zinc coordination by point-mutated structures of the distal CCHC binding motif of the HIV-1 NCp7 protein.

Elisa Bombarda1, Bernard P Roques, Yves Mély, Ernst Grell.   

Abstract

The kinetics of Zn(2+) binding by two point-mutated forms of the HIV-1 NCp7 C-terminal zinc finger, each containing tridentate binding motif HCC [Ser49(35-50)NCp7] or CCC [Ala44(35-50)NCp7], has been studied by stopped-flow spectrofluorimetry. Both the formation and dissociation rate constants of the complexes between Zn(2+) and the two model peptides depend on pH. The results are interpreted on the basis of a multistep reaction model involving three Zn(2+) binding paths due to three deprotonated states of the coordinating motif, acting as monodentate, bidentate, and tridentate ligands. For Ser49(35-50)NCp7 around neutral pH, binding preferentially occurs via the deprotonated Cys36 in the bidentate state also involving His44. The binding rate constants for the monodentate and bidentate states are 1 x 10(6) and 3.9 x 10(7) M(-)(1) s(-)(1), respectively. For Ala44(35-50)NCp7, intermolecular Zn(2+) binding predominantly occurs via the deprotonated Cys36 in the monodentate state with a rate constant of 3.6 x 10(7) M(-)(1) s(-)(1). In both mutants, the final state of the Zn(2+) complex is reached by subsequent stepwise ligand deprotonation and intramolecular substitution of coordinated water molecules. The rate constants for the intermolecular binding paths of the bidentate and tridentate states of Ala44(35-50)NCp7 and of the tridentate state of Ser49(35-50)NCp7 are much smaller than expected according to electrostatic considerations. This is attributed to conformational constraints required to achieve proper metal coordination during folding. The dissociation of Zn(2+) from both peptides is again characterized by a multistep process and takes place fastest via the protonated Zn(2+)-bound bidentate and monodentate states, with rate constants of approximately 0.3 and approximately 10(3) s(-)(1), respectively, for Ser49(35-50)NCp7 and approximately 4 x 10(-)(3) and approximately 500 s(-)(1), respectively, for Ala44(35-50)NCp7.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882070     DOI: 10.1021/bi047349+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

2.  Effect of mutation on the stabilization energy of HIV-1 zinc fingers: a hybrid local self-consistent field/molecular mechanics investigation.

Authors:  Nedjoua Drici; Mohamed Abdelghani Krallafa
Journal:  J Biol Inorg Chem       Date:  2016-11-15       Impact factor: 3.358

3.  Metal binding kinetics of bi-histidine sites used in psi analysis: evidence of high-energy protein folding intermediates.

Authors:  Gerra L Bosco; Michael Baxa; Tobin R Sosnick
Journal:  Biochemistry       Date:  2009-04-07       Impact factor: 3.162

4.  Characterization of the cofactor-induced folding mechanism of a zinc-binding peptide using computationally designed mutants.

Authors:  Jia Tang; Seung-Gu Kang; Jeffery G Saven; Feng Gai
Journal:  J Mol Biol       Date:  2009-04-08       Impact factor: 5.469

5.  Molecular mechanism of the Zn2+-induced folding of the distal CCHC finger motif of the HIV-1 nucleocapsid protein.

Authors:  Elisa Bombarda; Ernst Grell; Bernard P Roques; Yves Mély
Journal:  Biophys J       Date:  2007-04-06       Impact factor: 4.033

6.  Stability and folding behavior analysis of zinc-finger using simple models.

Authors:  Shan Chang; Xiong Jiao; Jian-Ping Hu; Yan Chen; Xu-Hong Tian
Journal:  Int J Mol Sci       Date:  2010-10-19       Impact factor: 5.923

Review 7.  Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.

Authors:  Mattia Mori; Lesia Kovalenko; Sébastien Lyonnais; Danny Antaki; Bruce E Torbett; Maurizio Botta; Gilles Mirambeau; Yves Mély
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.